NORD Announces Findings on Available Orphan Products, Generics and Biosimilars for Rare Diseases

March 26, 2021

The following is an excerpt from a press release from Sanofi. Read the full press release here. The National Organization for Rare Disorders (NORD®) announced the findings of a new study that details the number of orphan products, generics and biosimilars available to treat rare diseases. NORD commissioned Avalere to conduct the analysis to examine if laws and regulations are helping to bring new treatments to market for rare disease patients.  According to the report, the […]